Skip to main content
TipRanks
Go Ultimate75% OFF

Egetis Therapeutics AB (EGTX) Cash flow

1 Followers

Egetis Therapeutics AB Cash Flow

SE:EGTX's free cash flow for Q3 2026 was kr-100.50M. For the 2026 fiscal year, SE:EGTX's free cash flow was increased by kr0.00 and operating cash flow was kr-100.50M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
kr -267.10Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.11M
kr -2.80Mkr -1.20Mkr -100.00Kkr -1.70Mkr -5.96M
kr 140.00Mkr 270.90Mkr 458.90Mkr 155.70Mkr -8.90M
kr 215.80Mkr 351.00Mkr 303.30Mkr 127.70Mkr 143.97M
kr -268.60Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.28M

Currency in SEK

Egetis Therapeutics AB Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing